Award Data

The broader impact/commercial potential of this project is the assistive use by blind people of thermal imaging. The resulting product provides a person who is blind or visually impaired with the relevant information about the layout of an unfamiliar public space in order to assist blind users in everyday activities. Thermal imaging can differentiate people and objects from their background withou ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to more effectively treat serious, infectious corneal ulcers by delivering antibiotics directly to the eye?s surface via a novel, biodegradable flexible polymer film. The platform will deliver drug continuously, thereby eliminating the need for hourly eye drops. This product can be ad ...

The broader impact/ commercial potential of this Small Business Innovation Research (SBIR) Phase II project is aimed at reducing the impact of knee arthritis and improving the quality of life for those suffering from this debilitating condition, while simultaneously strengthening the bond between academia and industry by providing students with unique research opportunities through the development ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of a technology to accurately measure small RNA expression. This is an enabling life science research tool. Small RNAs are ubiquitous gene regulators found in the body. Products of the same microRNA gene that vary in length by one or two nucleotides may be involved in a hos ...

The broader commercial potential of this Small Business Innovation Research Phase II project is the commercial development of novel materials and processes for the immobilization of enzymes. The project is targeting enzymes as catalysts to be used in the manufacturing of active pharmaceutical intermediates (API). The use of enzyme for the production of pharmaceuticals has the potential to reduce c ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of a platform for the discovery of new anthelmintic (anti-parasite) drugs. Drug resistance is occurring with all anthelmintics currently on the market. Current drug development only introduces new molecules to the existing drug targets. As a result, drug resistance quickly ...

The broader impact/commercial potential of this project is the significant improvement of surgical accuracy, which will dramatically reduce surgical errors, improve outcomes and reduce healthcare costs. In spine surgery alone, there are more than 500,000 procedures every year in the US utilizing implants such as screws. In 4% to 11% of these surgeries, the implant placement is inaccurate. For the ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project involves advancements in the state-of-the-art in biomedical technology, improvement of the quality of care for intensive care unit (ICU) patients, and a reduction in healthcare costs. The proposed agitation and sedation system will assist in realizing an improved distribution of ICU workload ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is making tough, 3D printed parts that can be directly manufactured through additive processes commercially available. Additive manufacturing has potential to revolutionize the way parts are produced by streamlining product design, production, and validation, which allows for low production c ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to develop and commercialize radiation-tolerant integrated circuit (IC) technology for producing radiation-tolerant/hardened (rad-hard) ICs capable of being manufactured using leading-edge commercial IC processing instead of expensive specialized processes which use older, less effici ...